Medicine – Pregnancy and Epilepsy

Pregnancy in a woman with epilepsy requires careful planning because both uncontrolled seizures and antiseizure medications can affect maternal and fetal health. The central principle is to maintain good seizure control while using the lowest-risk effective antiseizure medication at the lowest effective dose, preferably as monotherapy when possible.

Older teaching often describes all antiepileptic drugs as having similar teratogenic effects. This is no longer accurate. Fetal risk differs substantially between individual antiseizure medications, with valproate carrying particularly important risks.

1. Epilepsy and Contraception

Some antiseizure medications induce hepatic enzymes and can increase the metabolism of hormonal contraceptives.

Important enzyme-inducing antiseizure medications include:

Carbamazepine.

Phenytoin.

Phenobarbital.

Primidone.

These drugs can reduce the effectiveness of some hormonal contraceptive methods.

2. Oral Contraceptive Pill and Enzyme-Inducing Drugs

The original teaching that the oral contraceptive pill may be less effective with enzyme-inducing antiseizure medications is correct.

Enzyme induction accelerates metabolism of contraceptive hormones and can reduce their circulating concentrations.

Therefore:

Carbamazepine or phenytoin + certain hormonal contraceptives → increased risk of contraceptive failure.

Contraceptive choice should be reviewed with the patient’s antiseizure medication.

3. Lamotrigine and the Combined Oral Contraceptive

There is another important interaction involving lamotrigine.

Estrogen-containing combined hormonal contraceptives can reduce lamotrigine concentrations, potentially worsening seizure control.

Therefore, the interaction can work in the opposite direction:

Some antiseizure drugs reduce contraceptive effectiveness.

Estrogen-containing contraception can reduce lamotrigine levels.

4. Antiseizure Medication Is Not Automatically Contraindicated in Pregnancy

Epilepsy treatment should not simply be stopped because a woman becomes pregnant.

Abrupt withdrawal may cause:

Breakthrough seizures.

Status epilepticus.

Maternal injury.

Fetal hypoxia.

Therefore, medication changes should be planned with specialist guidance.

5. Importance of Pre-Pregnancy Planning

Whenever possible, pregnancy should be planned in advance.

Preconception assessment allows clinicians to:

Review whether medication is still required.

Choose the safest effective drug.

Optimise the dose.

Consider monotherapy where possible.

Start folic acid supplementation.

Discuss maternal and fetal risks.

This is safer than making major medication changes after conception.

6. Risks of Uncontrolled Epilepsy

Uncontrolled seizures during pregnancy can endanger both mother and fetus.

Generalised tonic-clonic seizures are particularly concerning because they may cause:

Maternal trauma.

Falls.

Hypoxia.

Aspiration.

Status epilepticus.

Fetal hypoxia or distress.

Therefore, maintaining seizure control remains a major priority.

7. Do Not Stop Medication Abruptly

A pregnant patient taking antiseizure medication should not abruptly stop treatment without medical advice.

Sudden discontinuation can precipitate severe seizures.

The aim is not to eliminate medication at all costs but to achieve:

Maximum seizure control with minimum fetal drug exposure.

8. Fetal Malformation Risk

Pregnancy in women with epilepsy requires discussion of congenital malformation risk.

However, the original statement that fetal malformations are 25% higher even in untreated epilepsy should be interpreted cautiously.

Modern evidence suggests that much of the increased congenital-malformation risk is related to specific antiseizure medications, dose, and polytherapy, rather than epilepsy itself producing a large uniform increase in risk.

9. Not All Antiseizure Medications Have the Same Teratogenic Risk

The older statement that all antiepileptic drugs cause approximately three times the normal teratogenic risk is too broad.

Different drugs have very different pregnancy safety profiles.

Some have relatively low observed major congenital malformation rates, whereas others—particularly valproate—carry substantially greater risks.

10. Valproate

Sodium valproate is particularly important in pregnancy because of its high fetal risk.

Exposure is associated with increased risk of major congenital malformations, including:

Neural tube defects.

Cardiac abnormalities.

Craniofacial abnormalities.

Limb abnormalities.

It is also associated with adverse neurodevelopmental outcomes.

11. Neurodevelopmental Effects of Valproate

Prenatal valproate exposure has been associated with increased risk of:

Developmental delay.

Lower cognitive performance.

Autism spectrum disorder.

Other neurodevelopmental difficulties.

For this reason, valproate is subject to particularly strict pregnancy-prevention and prescribing restrictions in many healthcare systems.

12. Lamotrigine

Lamotrigine is commonly considered one of the more pregnancy-compatible antiseizure medications when clinically appropriate.

However, pregnancy can substantially increase its clearance.

This means lamotrigine concentrations may fall during pregnancy, potentially leading to breakthrough seizures.

Therefore, dose and/or serum concentration monitoring may be required.

13. Levetiracetam

Levetiracetam is another commonly used option with comparatively reassuring pregnancy safety data.

As with any antiseizure medication, the choice depends on:

Seizure type.

Epilepsy syndrome.

Previous treatment response.

Individual pregnancy risks.

14. Carbamazepine

Carbamazepine has long been used during pregnancy.

It carries some teratogenic risk, including an association with neural tube defects, but its overall fetal risk is generally lower than that associated with valproate.

It is also an enzyme inducer, which is relevant when contraception is being used before pregnancy.

15. Phenytoin

Phenytoin exposure during pregnancy is associated with congenital abnormalities and the historically described fetal hydantoin syndrome.

Features can include:

Craniofacial abnormalities.

Growth restriction.

Limb or nail abnormalities.

Therefore, medication choice should be individualised rather than assuming all antiseizure drugs have equal risk.

16. Monotherapy versus Polytherapy

Where seizure control permits, monotherapy is generally preferred over multiple antiseizure medications.

The principle is:

One appropriate drug at the lowest effective dose.

However, seizure control should not be sacrificed simply to achieve monotherapy.

17. Folic Acid

Women taking antiseizure medication who may become pregnant should receive folic acid supplementation according to local preconception guidance.

Folic acid is particularly important because neural tube development occurs very early in pregnancy, often before a woman knows she is pregnant.

It should ideally be started before conception.

18. Why Folic Acid Is Important

Folate is required for normal neural tube development.

Adequate folate supplementation reduces the risk of neural tube defects in the general population and is routinely recommended around conception.

Women taking antiseizure medication may be advised to take a higher-dose preparation depending on the drug and national guideline.

Therefore, the exact dose should follow current local guidance rather than assuming one dose applies universally.

19. Monitoring During Pregnancy

Pregnancy can alter the pharmacokinetics of antiseizure medications.

Drug concentrations may fall because of changes in:

Plasma volume.

Protein binding.

Renal clearance.

Hepatic metabolism.

This is especially clinically important for drugs such as lamotrigine and levetiracetam.

20. Seizure Control During Pregnancy

Many women remain stable during pregnancy, but seizure frequency can increase in some patients.

Possible contributing factors include:

Falling medication concentrations.

Vomiting.

Poor adherence.

Sleep deprivation.

Stress.

Regular neurological and obstetric follow-up is therefore important.

21. Labour and Delivery

Most women with epilepsy can have a vaginal delivery.

Epilepsy alone is not an indication for caesarean section.

Regular antiseizure medication should generally be continued during labour, and factors that can precipitate seizures—particularly sleep deprivation and missed medication—should be minimised.

22. Breastfeeding

The original statement that there is no general contraindication to breastfeeding while taking antiseizure medication is broadly correct.

For many commonly used antiseizure medications, breastfeeding is possible and often encouraged after individual assessment.

However, drug transfer into breast milk varies.

23. Monitoring the Breastfed Infant

Depending on the medication, the infant may need observation for:

Excessive sedation.

Poor feeding.

Poor weight gain.

Reduced alertness.

Therefore, breastfeeding decisions should consider the particular drug rather than applying an absolute rule to every antiseizure medication.

24. Risk of Epilepsy in the Child

Children of parents with epilepsy have a somewhat increased risk of developing epilepsy compared with the general population.

The original figure of approximately 3% is a useful rough teaching estimate for some situations, but there is no single risk applicable to every patient.

The actual risk depends strongly on:

The parent’s epilepsy syndrome.

Whether there is a known genetic cause.

Family history.

Whether one or both parents are affected.

Some genetically determined epilepsy syndromes carry substantially higher recurrence risks.

25. Pregnancy and Epilepsy – Note Form

Main principle: maintain maternal seizure control while minimising fetal medication risk.

Do not abruptly stop antiseizure medication during pregnancy.

Enzyme-inducing drugs: carbamazepine, phenytoin, phenobarbital and primidone can reduce the effectiveness of some hormonal contraceptives.

Lamotrigine: estrogen-containing contraceptives can lower lamotrigine concentrations.

Preconception: review medication before pregnancy whenever possible.

Preferred strategy when appropriate: effective monotherapy at the lowest effective dose.

Highest-concern drug: valproate because of major congenital and neurodevelopmental risks.

Lower-risk commonly used options when appropriate: lamotrigine and levetiracetam have comparatively reassuring pregnancy data.

Folic acid: start before conception according to local guidance.

Pregnancy monitoring: drug concentrations may change, particularly with lamotrigine and levetiracetam.

Uncontrolled seizures: can cause maternal trauma, hypoxia and fetal compromise.

Delivery: vaginal delivery is usually possible.

Breastfeeding: generally possible with many antiseizure medications, with drug-specific assessment.

Child’s epilepsy risk: increased above background, but the traditional ~3% figure is only an approximate estimate and varies with epilepsy type and genetics.

26. Important Corrections to the Older Teaching

“All antiepileptic drugs have three times the teratogenic risk” → Not accurate.

Teratogenic risk differs considerably between drugs.

“Epilepsy without medication increases malformations by 25%” → Too simplistic.

Epilepsy itself does not appear to produce the same degree of congenital-malformation risk as high-risk antiseizure medication exposure.

“Folic acid decreases all malformations” → Too broad.

Folic acid is particularly important for neural tube development and should be used preconceptionally, but it does not eliminate the teratogenic effects of high-risk antiseizure medications.

“Child’s epilepsy risk is exactly 3%” → Approximation only.

Risk depends strongly on the underlying epilepsy syndrome and genetic background.

Key Clinical Pattern

Think of pregnancy and epilepsy as a balance between:

SEIZURE CONTROL ↔ FETAL MEDICATION RISK.

The practical principles are:

Plan pregnancy + review antiseizure medication + avoid abrupt withdrawal + use the safest effective regimen + give folic acid + monitor throughout pregnancy.

The most important drug association to remember is:

VALPROATE → particularly high risk of congenital malformations and adverse neurodevelopmental outcomes.

And for contraception:

ENZYME-INDUCING ANTISEIZURE DRUGS → some hormonal contraceptives become less effective.